Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Infectious diseases remain one of the leading causes of morbidity and mortality worldwide. The WHO and CDC have expressed serious concern regarding the continued increase in the development of multidrug resistance among bacteria. Therefore, the antibiotic resistance crisis is one of the most pressin...
Main Authors: | Pedro V. Baptista, Matthew P. McCusker, Andreia Carvalho, Daniela A. Ferreira, Niamh M. Mohan, Marta Martins, Alexandra R. Fernandes |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2018.01441/full |
Similar Items
-
Unlocking NuriPep 1653 From Common Pea Protein: A Potent Antimicrobial Peptide to Tackle a Pan-Drug Resistant Acinetobacter baumannii
by: Niamh Maire Mohan, et al.
Published: (2019-09-01) -
Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
by: Kaitlin S. Witherell, et al.
Published: (2020-09-01) -
Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
by: Pooi Yin Chung, et al.
Published: (2017-08-01) -
Isolates, Antimicrobial Susceptibility Profiles and Multidrug Resistance of Bacteria Cultured from Pig Submissions in New Zealand
by: Christopher B. Riley, et al.
Published: (2020-08-01) -
Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs
by: William O. Hahn, et al.
Published: (2016-11-01)